Goldman Sachs’s TransCode Therapeutics RNAZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$219K Buy
2023
Q2
Hold
2023
Q1
Hold
2022
Q4
Hold